PubMed COVID-19 Clinical Care
541 - 550 of 851 results found
Vaccination in sickle cell disease: Immunocompromised or immunocompetent?
Description
Sickle cell disease (SCD) is an immunocompromised condition and patients with SCD may have a reduced immune response to certain vaccinations. The report by Nakahara et al. demonstrated that SCD patients exhibited elevated and more sustained IgG
VANGL2 inhibits antiviral IFN-I signaling by targeting TBK1 for autophagic degradation
Description
Stringent control of type I interferon (IFN-I) signaling is critical to potent innate immune responses against viral infection, yet the underlying molecular mechanisms are still elusive. Here, we found that Van Gogh-like 2 (VANGL2) acts as an IFN
Validating model output in the absence of ground truth data: A COVID-19 case study using the Simulator of Infectious Disease Dynamics in North Carolina (SIDD-NC) model
Description
As the COVID-19 pandemic has progressed, various models have been developed to forecast changes in the outbreak and assess intervention strategies. In this study we validate the Simulator of Infectious Disease Dynamics in North Carolina (SIDD-NC)
Viral hepatitis in Asia-Pacific: a post-COVID-19 reset
Description
No abstract
Vaccination approach in patients with an allergic reaction to COVID-19 vaccines or at risk of developing allergic reactions
Description
CONCLUSIONS: Considering the potentially life-saving benefits of vaccination in a global pandemic environment, it is a safe and effective method to administer vaccines to at-risk patients using desensitization or split dosing techniques, based on
Vaccination status of COVID-19 patients followed up in the ICU in a country with heterologous vaccination policy: A multicenter national study in Turkey
Description
CONCLUSION: Despite effective vaccination, fully vaccinated patients may be admitted to ICU because of disease severity. Unvaccinated patients were younger and had fewer comorbid conditions. Unvaccinated patients have an increased risk of 28-day
VV116 or Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19. Reply
Description
No abstract
Viral evasion of the interferon response at a glance
Description
Re-emerging and new viral pathogens have caused significant morbidity and mortality around the world, as evidenced by the recent monkeypox, Ebola and Zika virus outbreaks and the ongoing COVID-19 pandemic. Successful viral infection relies on
